🇺🇸 FDA
Pipeline program

bismuth-containing quadral therapy based on antibiotic susceptibility

2018SDU-QILU-G113

Unknown small_molecule active

Quick answer

bismuth-containing quadral therapy based on antibiotic susceptibility for Helicobacter Pylori is a Unknown program (small_molecule) at Shandong University with 1 ClinicalTrials.gov record(s).

Program details

Company
Shandong University
Indication
Helicobacter Pylori
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials